-+ 0.00%
-+ 0.00%
-+ 0.00%
Ocugen Presents Gene Therapy Platform at Investor and Industry Conferences
Share
Listen to the news
Ocugen Presents Gene Therapy Platform at Investor and Industry Conferences
  • Ocugen will present at Stifel 2026 Healthcare Conference in New York on Nov. 12, 2026, from 10:00-10:30 a.m. ET.
  • CEO Shankar Musunuri will discuss the company's modifier gene therapy platform.
  • Musunuri will join a Cell & Gene Leaders Live 2026 panel at London's Shard on Nov. 15, 2026, from 3:15-4:00 p.m. GMT.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610290702PRIMZONEFULLFEED9855009) on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending